Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D O Stram

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Medical and Pediatric Oncology|July 24, 2001
Comprehensive analysis of chromosome 1p deletions in neuroblastomaJ M Maris, C Guo, D Blake, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group studyK K Matthay, C Perez, R C Seeger, et al.
American Journal of Epidemiology|March 1, 2000
Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los AngelesD O Stram, J H Hankin, L R Wilkens, et al.
The New England Journal of Medicine|October 16, 1999
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer GroupK K Matthay, J G Villablanca, R C Seeger, et al.
Epidemiology (Cambridge, Mass.)|July 1, 1996
Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intakeM P Longnecker, D O Stram, P R Taylor, et al.
Journal of Pediatric Hematology/Oncology|June 11, 1999
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survivalS G DuBois, Y Kalika, J N Lukens, et al.
Medical and Pediatric Oncology|July 24, 2001
Loss of heterozygosity for chromosome 14q in neuroblastomaP M Thompson, B A Seifried, S K Kyemba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group studyJ M Maris, M J Weiss, C Guo, et al.
British Journal of Cancer|January 26, 2008
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysisC L Pearce, A H Wu, S A Gayther, et al.
Nature Reviews. Cancer|December 13, 2005
A candidate gene approach to searching for low-penetrance breast and prostate cancer genesD J Hunter, E Riboli, C A Haiman, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Medical and Pediatric Oncology|July 24, 2001
Comprehensive analysis of chromosome 1p deletions in neuroblastomaJ M Maris, C Guo, D Blake, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group studyK K Matthay, C Perez, R C Seeger, et al.
American Journal of Epidemiology|March 1, 2000
Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los AngelesD O Stram, J H Hankin, L R Wilkens, et al.
The New England Journal of Medicine|October 16, 1999
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer GroupK K Matthay, J G Villablanca, R C Seeger, et al.
Epidemiology (Cambridge, Mass.)|July 1, 1996
Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intakeM P Longnecker, D O Stram, P R Taylor, et al.
Journal of Pediatric Hematology/Oncology|June 11, 1999
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survivalS G DuBois, Y Kalika, J N Lukens, et al.
Medical and Pediatric Oncology|July 24, 2001
Loss of heterozygosity for chromosome 14q in neuroblastomaP M Thompson, B A Seifried, S K Kyemba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group studyJ M Maris, M J Weiss, C Guo, et al.
British Journal of Cancer|January 26, 2008
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysisC L Pearce, A H Wu, S A Gayther, et al.
Nature Reviews. Cancer|December 13, 2005
A candidate gene approach to searching for low-penetrance breast and prostate cancer genesD J Hunter, E Riboli, C A Haiman, et al.
Pageof 9